Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C24H30N4O |
| Molecular Weight | 390.5212 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCCNC(=O)CN1N=CC(=C1C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=PRHCHMGCDBUACR-UHFFFAOYSA-N
InChI=1S/C24H30N4O/c1-3-27(4-2)17-11-16-25-23(29)19-28-24(21-14-9-6-10-15-21)22(18-26-28)20-12-7-5-8-13-20/h5-10,12-15,18H,3-4,11,16-17,19H2,1-2H3,(H,25,29)
| Molecular Formula | C24H30N4O |
| Molecular Weight | 390.5212 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Ipazilide is an antiarrhythmic agent that prolongs ventricular refractoriness and possesses antiectopic activity. In clinical trials ipazilide administrations leads to dose- and time-dependent in decrease cardiac index and arterial pressure. Left ventricular filling pressure, right atrial pressure, and heart rate were not altered by ipazilide. Plasma concentrations of ipazilide peaked 90 minutes after administration of 100 or 200 of the drug, but peak concentrations were noted 3 hours after administration of 400 mg. The hemodynamic response correlated with the plasma concentration of ipazilide determined contemporaneously.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Potassium channel Sources: https://adisinsight.springer.com/drugs/800001765 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8033497
400, 200, and 100 mg single-dose
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:44:50 GMT 2025
by
admin
on
Mon Mar 31 18:44:50 GMT 2025
|
| Record UNII |
WDN6V96D5U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47793
Created by
admin on Mon Mar 31 18:44:50 GMT 2025 , Edited by admin on Mon Mar 31 18:44:50 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2111169
Created by
admin on Mon Mar 31 18:44:50 GMT 2025 , Edited by admin on Mon Mar 31 18:44:50 GMT 2025
|
PRIMARY | |||
|
C83832
Created by
admin on Mon Mar 31 18:44:50 GMT 2025 , Edited by admin on Mon Mar 31 18:44:50 GMT 2025
|
PRIMARY | |||
|
WDN6V96D5U
Created by
admin on Mon Mar 31 18:44:50 GMT 2025 , Edited by admin on Mon Mar 31 18:44:50 GMT 2025
|
PRIMARY | |||
|
SUB08270MIG
Created by
admin on Mon Mar 31 18:44:50 GMT 2025 , Edited by admin on Mon Mar 31 18:44:50 GMT 2025
|
PRIMARY | |||
|
100000083119
Created by
admin on Mon Mar 31 18:44:50 GMT 2025 , Edited by admin on Mon Mar 31 18:44:50 GMT 2025
|
PRIMARY | |||
|
DTXSID2043799
Created by
admin on Mon Mar 31 18:44:50 GMT 2025 , Edited by admin on Mon Mar 31 18:44:50 GMT 2025
|
PRIMARY | |||
|
115436-73-2
Created by
admin on Mon Mar 31 18:44:50 GMT 2025 , Edited by admin on Mon Mar 31 18:44:50 GMT 2025
|
PRIMARY | |||
|
6567
Created by
admin on Mon Mar 31 18:44:50 GMT 2025 , Edited by admin on Mon Mar 31 18:44:50 GMT 2025
|
PRIMARY | |||
|
60650
Created by
admin on Mon Mar 31 18:44:50 GMT 2025 , Edited by admin on Mon Mar 31 18:44:50 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |